Axa’s Core Laboratories CLB Stock Holding History

Axa’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-38,292	Closed	-$1.44M	–	1183
2019 Q4	$1.44M	Hold	38,292	–	–	0.01%	847
2019 Q3	$1.78M	Hold	38,292	–	–	0.01%	886
2019 Q2	$2M	Hold	38,292	–	–	0.01%	851
2019 Q1	$2.64M	Hold	38,292	–	–	0.01%	800
2018 Q4	$2.29M	Sell	38,292 -5,913	-13%	-$510K	0.01%	790
2018 Q3	$5.12M	Buy	44,205 +548	+1%	+$61.8K	0.02%	665
2018 Q2	$5.51M	Buy	43,657 +8,396	+24%	+$1.02M	0.02%	631
2018 Q1	$3.82M	Buy	35,261 +20,455	+138%	+$2.26M	0.02%	722
2017 Q4	$1.62M	Buy	+14,806	New	+$1.48M	0.01%	902
2017 Q1	–	Sell	-2,357	Closed	-$283K	–	1274
2016 Q4	$283K	Buy	+2,357	New	+$261K	﹤0.01%	1154
2016 Q3	–	Sell	-1,400	Closed	-$173K	–	1216
2016 Q2	$173K	Buy	1,400 +679	+94%	+$82K	﹤0.01%	1186
2016 Q1	$81K	Hold	721	–	–	﹤0.01%	1226
2015 Q4	$78K	Sell	721 -1,421	-66%	-$163K	﹤0.01%	1263
2015 Q3	$214K	Buy	+2,142	New	+$233K	﹤0.01%	1199
2014 Q2	–	Sell	-18,000	Closed	-$3.57M	–	1390
2014 Q1	$3.57M	Sell	18,000 -1,000	-5%	-$189K	0.02%	610
2013 Q4	$3.63M	Sell	19,000 -18,306	-49%	-$3.41M	0.02%	609
2013 Q3	$6.31M	Sell	37,306 -33,322	-47%	-$5.17M	0.03%	471
2013 Q2	$10.7M	Buy	+70,628	New	+$10M	0.06%	322

Other funds holding CLB

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Axa's CLB Position: Q1 2020 in Review

Axa sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 38,292 shares — an estimated $1.44M sold.

Axa first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $10.7M in Q2 2013. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

Axa reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
Axa sold 38,292 Core Laboratories shares in Q1 2020, an estimated $1.44M.
Axa first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
Axa's Core Laboratories position peaked at $10.7M in Q2 2013.
207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Axa's 13F filing for Q1 2020, filed 15 May 2020.